04-Jan-2007

PerkinElmer, Inc. announced the acquisition of a line of Dynamic Mechanical Analysis (DMA) products from UK-based Triton Technology Ltd. The DMA instrument is used by scientists in the polymers, pharmaceuticals and food industries for diverse applications ranging from simple quality control to ...

more

04-Dec-2006

PerkinElmer, Inc. announced that it has signed a definitive agreement with Evotec AG to acquire its majority owned subsidiary, Evotec Technologies GmbH, in a cash transaction valued at approximately EUR 23 million. The transaction is subject to regulatory approvals and other customary closing ...

more

Adding Raman Spectroscopy Capability

07-Sep-2006

PerkinElmer, Inc. announced the acquisition of Avalon Instruments Limited, based in Belfast, Northern Ireland. The acquisition expands and complements PerkinElmer's Molecular Spectroscopy product portfolio through adding a family of bench-top dispersive Raman spectrometers. The Avalon Raman ...

more

21-Jul-2006

PerkinElmer Inc., announced that Dr. Richard Eglen has joined the Company as vice president and general manager, discovery and research reagents for PerkinElmer's Life & Analytical Sciences unit. In this position, Eglen is responsible for developing and executing PerkinElmer's discovery and ...

more

12-Jun-2006

PerkinElmer, Inc. announced that its neonatal screening technology has been selected by State of Israel's Chaim Sheba Medical Center, Tel Aviv, to create a comprehensive newborn screening program that is intended to cover every child born in Israel. Under the terms of this agreement, PerkinElmer ...

more

09-Jun-2006

PerkinElmer, Inc. announced the acquisition of United Kingdom-based Clinical & Analytical Service Solutions Ltd. (C&A), a scientific equipment asset and managed maintenance company serving the pharmaceutical, biotechnology and healthcare markets. C&A, which generated revenues of approximately ...

more

16-May-2006

PerkinElmer, Inc. announced the appointment of Dr. Daniel R. Marshak as vice president and chief scientific officer for the Company. Marshak will be responsible for setting the strategic direction of PerkinElmer's research and development functions, and helping drive its growth strategies in the ...

more

02-Mar-2006

PerkinElmer Inc. announced that, in line with its previously announced intention, the Company has sold the assets of its semiconductor components business to Tara Capital for cash and assumed liabilities totaling approximately $26.5 million and an earn out that could increase the total ...

more

23-Feb-2006

PerkinElmer Inc. announced the opening of a new technology center in Shanghai, China, that will expand the company's presence in that country and consolidate three current Shanghai locations. The center will bring together PerkinElmer's sales, service, customer care and technology support ...

more

Appointment Positions Company for Future Growth in Molecular Medicine

19-Jan-2006

PerkinElmer, Inc. announced its appointment of Dr. Karl Hecker as Director of Research & Development (R&D) for its Boston-based Center of Excellence. He will lead all product R&D efforts for the Center, which focuses on molecular medicine solutions for the company's Life and Analytical Sciences ...

more